查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1136902

全球诊断导管市场-2022-2029

Global Diagnostic Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球诊断导管市场的增长受到全球心血管手术数量不断增加、外科手术以及微创手术趋势等因素的推动。

不断涌现的新颖和创新技术进步正在推动市场增长。

与诊断导管相关的技术进步正在推动全球市场增长。例如，2021 年 6 月，雅培宣布它可以支持对机械循环支持设备不断增长的需求，以充分治疗晚期心力衰竭。

根据国家健康和营养检查调查 (NHANES) 数据 (2020)，估计有 620 万美国 20 岁及以上成年人 (2.2%) 患有心力衰竭。超过 570 万美国人患有心力衰竭，每年诊断出大约 915,000 例新病例。由于不健康的生活方式和环境变化，心力衰竭、心血管疾病和冠状动脉疾病等慢性疾病的患病率在全球范围内不断增加。这些最新的产品发布和技术进步将能够对抗这些疾病。例如，2022 年 4 月，富兰克林医疗山宣布其经皮导管系统 UltraNav 已获得美国食品和药物管理局的批准。它通过经皮穿刺提供心血管导管的受控输送。

主要关键参与者正在生产新颖和创新的产品，这些关键参与者正在进行各种管道和研究以推动市场增长。例如，2022 年 8 月，阿斯利康公布了 DAPA-HF 和 DELIVER 的 3 期试验分析的新结果，表明 Falixiga 与安慰剂相比在心力衰竭患者中的□□死亡率益处。

与诊断导管相关的副作用阻碍了市场增长。

然而，熟练医务人员的短缺、严格的政府法规以及副作用的出现阻碍了市场的发展。其中，副作用的发生有望抑制市场。例如，中风、化学过敏和食道损伤在普通人群中很少见。

COVID-19 影响分析

与 Covid-19 传播相关的封锁和旅行限制给新的诊断导管製造商带来了问题。由于 COVID-19 感染的传播对主要经济体产生了重大影响，诊断性导管插入药物的生产受到了很大影响。

市场参与者正在改变他们的长期和短期增长战略，利用研究市场和创造尖端产品来抗击这一流行病。即使 COVID-19 对诊断导管行业造成影响，尽快制定业务运营的备用计划也很重要。

您将可以访问全球诊断导管市场报告中大约 40 多个市场数据表、45 多个数字和 200 页（大约）。

内容

第一章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 技术进步的增加
      • 增加创新产品的推出
    • 约束因素
      • 与诊断导管相关的副作用
      • 缺乏经验丰富的专业人员
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按技术分类

  • 影像诊断
    • 血管造影导管
    • MRI 引导导管
    • 血管内超声导管 (IVUS)
    • 电生理图 (EP)
    • 心输出量导管
  • 非影像诊断
    • 压力监测导管
    • 流量监测导管
    • 血氧导管
    • 体温监测导管
    • 重症监护监控系统

第 8 章按产品类型

  • 固定曲线导管
  • 导嚮导管
  • 高级映射导管

第 9 章。按应用程序

  • 循环区
  • 肠胃科
  • 泌尿科
  • 神经科

第 10 章，最终用户

  • 医院
  • 诊断中心
  • 专科诊所
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 13 章公司简介

  • B.Braun Melsungen AG
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Abbott
  • Medtronic
  • Boston Scientific
  • Infiniti Medical
  • Merit Medical
  • Osypka AG
  • Terumo Corporation
  • Johnson & Johnson
  • Royal Philips

第 14 章全球诊断导管市场-DataM

简介目录
Product Code: DMCD873

Market Overview

Diagnostic Catheter Market was valued at US$ 4,292.31 million in 2021 and is estimated to reach US$ 6,628.54 million by 2029, growing at a CAGR of 7.04% during the forecast period (2022-2029).

A diagnostic catheter is a thin plastic tube inserted into the artery through a small incision on the skin. Once the catheter is guided to the area to be examined, a contrast material (radiopaque media or therapeutic agent) is injected through the tube and images or required information are captured using technological equipment such as (micro cameras, x-ray fluids, pressure monitors, etc.).

Market Dynamics

The global diagnostic catheter market growth is driven by factors, such as the increase in cardiovascular surgeries globally, surgical procedures, and an inclination towards minimally invasive surgeries.

The increasing number of novel, innovative technological advancements are driving the market growth.

The market is driven by the increasing technological advancements related to diagnostic catheters fuelling the market's growth globally. For instance, in Jun 2021, Abbott announced that the company could support the growing demand for mechanical circulatory support devices to treat advanced heart failure properly.

According to the National Health and Nutrition Examination Survey (NHANES) data (2020), an estimated 6.2 million American adults ≥20 years of age (2.2%) had heart failure. More than 5.7 million Americans suffer from heart failure, and approximately 915,000 new patients are diagnosed annually. The prevalence of chronic ailments like heart failure, cardiovascular disease, and coronary artery disease is increasing due to unhealthy lifestyles and changing environments worldwide. These latest product launches and technological advances will be able to combat these diseases. For instance, In Apr 2022, Franklin Medical Mountain announced it received approval for UltraNav, a transseptal catheter system, from the United States Food and Drug Administration. It will provide controlled delivery of cardiovascular catheters by the transseptal puncture.

Major key players are producing novel, innovative products and various pipelines and studies are being conducted by these key players to derive market growth. For instance, in Aug 2022, AstraZeneca presented its novel results from the analysis of phase III trials of DAPA-HF and DELIVER that shows the mortality benefit of Farxiga over placebo in heart failure patients.

The side effects associated with diagnostic catheters will hamper the market's growth.

However, the lack of skilled medical professionals, stringent government regulations, and the onset of side effects hamper the market. Among these, the onset of side effects is expected to restrain the market. For instance, stroke, chemical allergies, and esophageal injury are seen in less percentage of the total population.

COVID-19 Impact Analysis

Due to lockdowns and travel restrictions brought on by the spread of COVID-19, makers of novel diagnostic catheters experienced problems. Because the spread of COVID-19 infections badly impacted major economies, diagnostic catheter therapeutics production was greatly impacted.

Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harmed the diagnostic catheter industry, preparing and implementing backup plans as soon as possible for business operations is crucial.

Segment Analysis

The imaging diagnostic catheters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The imaging diagnostic has the largest market share in the forecast period. Electrophysiology mapping (EP) devices sub segment hold the largest market share as these catheter devices are often used to confirm the atrial fibrillation diagnosis and to decide its most suitable treatment. Due to its incorporated mapping capability, the usage of EP mapping catheters is increasing. The non-mapping electrophysiology catheters are less expensive than mapping ones as they do not provide the mapping. Various latest innovations are leading towards the growth of the market. For instance, in Jan 2022, Abbott announced that its cardiac mapping platform, Ensite X EP system with Omnipolar technology, got clearance from the U.S. FDA. This mapping system is developed to assist physicians in better treatment of cardiac arrhythmias. It provides the heart's detailed three-dimensional map as it's designed with the electrophysiologist's inputs.

Geographical Analysis

The North American region holds the largest global diagnostic catheter market.

North America dominates the diagnostic catheter market and is expected to show a similar trend over the forecast period. The growth of North American diagnostic catheters can be attributed to the rising prevalence of heart failure cases and the surge in the geriatric population. Strong healthcare infrastructure and an increase in research and development expenditure are to blame for this supremacy. Furthermore, the rising prevalence of cardiovascular diseases in this region due to unhealthy lifestyles and diets has propelled diagnostic catheter demand in the market.

According to the American Heart Association report 2020, approximately 790,000 people in the U.S. have heart attacks yearly. The rising number of people suffering from cardiovascular diseases and growing technological advancements and mergers or acquisitions by key players boost the demand for diagnostic catheter treatment in this region. For instance, in Jun 2021, Abiomed announced its acquisition of a precardiac catheter developer that provides less invasive options for treating patients with acute decompensated heart failure.

Competitive Landscape

The diagnostic catheter market is highly competitive with local and global companies. Some key players contributing to the market's growth are B. Braun Melsungen AG, Abbott, Medtronic, Boston Scientific, Infiniti Medical, Merit Medical, Osypka AG, Terumo Corporation, and Royal Philips, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the diagnostic catheter market globally. For instance, in Feb 2022, Interrad Medical, a private company of medical devices, and Eloquest Healthcare announced their strategic partnership to expand SecurAcath sales in the U.S.

B. Braun Melsungen AG.

Overview:

B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and established in 1839. They provide services in around 60 countries and employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Angiodyn diagnostic catheters: Angiodyn diagnostic catheters are used for coronary angiographies. For 1:1 force transmission, it contains a symmetrical braided shaft.

Key Development:

In Jul 2022, B. Braun Medical Inc., a developer of infusion therapy, launched its one-time blood control Introcan safety 2 IV catheter. It is developed for safe IV access.

The global diagnostic catheter market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing novel technological advancements
      • 4.1.1.2. Growing innovative product launches
    • 4.1.2. Restraints:
      • 4.1.2.1. The side effects associated with these diagnostic catheters
      • 4.1.2.2. Unavailability of experienced professional
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Imaging *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Angiography catheters
    • 7.2.4. MRI-guided catheters
    • 7.2.5. Intravascular ultrasonic catheters (IVUS)
    • 7.2.6. Electrophysiology mapping (EP)
    • 7.2.7. Cardiac output catheters
  • 7.3. Non-Imaging
    • 7.3.1. Pressure monitoring catheters
    • 7.3.2. Flow monitoring catheters
    • 7.3.3. Oximetry catheters
    • 7.3.4. Temperature monitoring catheters
    • 7.3.5. Critical care monitoring systems

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Fixed curve Catheters *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Steerable Catheters
  • 8.4. Advanced mapping Catheters

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Cardiology*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Gastroenterology
  • 9.4. Urology
  • 9.5. Neurology

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospital*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Centers
  • 10.4. Specialty Clinics
  • 10.5. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. B.Braun Melsungen AG*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Abbott
  • 13.3. Medtronic
  • 13.4. Boston Scientific
  • 13.5. Infiniti Medical
  • 13.6. Merit Medical
  • 13.7. Osypka AG
  • 13.8. Terumo Corporation
  • 13.9. Johnson & Johnson
  • 13.10. Royal Philips

LIST NOT EXHAUSTIVE

14. Global Diagnostic Catheter Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us